Cargando…
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors
Pancreatic neuroendocrine tumors (PNETs) are heterogeneous neoplasms which represent only 2% of all pancreatic neoplasms by incidence, but 10% by prevalence. Genetic risk factors could have an important role in the disease aetiology, however only a small number of case control studies have been perf...
Autores principales: | Campa, Daniele, Capurso, Gabriele, Pastore, Manuela, Talar-Wojnarowska, Renata, Milanetto, Anna Caterina, Landoni, Luca, Maiello, Evaristo, Lawlor, Rita T., Malecka-Panas, Ewa, Funel, Niccola, Gazouli, Maria, De Bonis, Antonio, Klüter, Harald, Rinzivillo, Maria, Delle Fave, Gianfranco, Hackert, Thilo, Landi, Stefano, Bugert, Peter, Bambi, Franco, Archibugi, Livia, Scarpa, Aldo, Katzke, Verena, Dervenis, Christos, Liço, Valbona, Furlanello, Sara, Strobel, Oliver, Tavano, Francesca, Basso, Daniela, Kaaks, Rudolf, Pasquali, Claudio, Gentiluomo, Manuel, Rizzato, Cosmeri, Canzian, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5180167/ https://www.ncbi.nlm.nih.gov/pubmed/28008994 http://dx.doi.org/10.1038/srep39565 |
Ejemplares similares
-
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival
por: Mohelnikova-Duchonova, Beatrice, et al.
Publicado: (2017) -
Primary leiomyosarcoma of the pancreas: report of a case treated by local excision and review of the literature
por: Milanetto, Anna Caterina, et al.
Publicado: (2015) -
Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival
por: Gentiluomo, Manuel, et al.
Publicado: (2021) -
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression
por: Gentiluomo, Manuel, et al.
Publicado: (2023) -
Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk
por: Campa, Daniele, et al.
Publicado: (2016)